Heron Therapeuti
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $37,666 | $34,711 | $40,588 | $38,213 |
Gross Profit | 26,094 | 24,073 | 32,939 | 22,829 |
EBITDA | -5,489 | -7,582 | -792 | -13,980 |
EBIT | -8,111 | -1,954 | -14,595 | |
Net Income | -5,489 | -8,111 | -2,954 | -17,495 |
Net Change In Cash | 37,666 | 34,711 | 40,588 | 38,213 |
Free Cash Flow | -2,351 | -1,931 | -9,184 | 1,331 |
Cash | 20,721 | 26,117 | 28,647 | 43,068 |
Basic Shares | 190,335 | 189,646 | 166,707 | 170,348 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $154,904 | $144,285 | $127,044 | $107,672 |
Gross Profit | 113,557 | 105,637 | 61,939 | 52,798 |
EBITDA | -17,881 | -5,056 | -103,792 | -171,769 |
EBIT | -20,195 | -7,548 | -106,691 | -174,658 |
Net Income | -20,195 | -13,580 | -110,559 | -134,516 |
Net Change In Cash | 154,904 | 144,285 | 127,044 | 107,672 |
Free Cash Flow | -27,908 | -24,235 | -60,334 | -148,737 |
Cash | 28,647 | 25,802 | 28,677 | 15,364 |
Basic Shares | 166,707 | 152,449 | 138,135 | 108,996 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.03 |
2026-03-31 | -$0.04 |
2025-12-31 | -$0.02 |
2025-09-30 | -$0.04 |